Model N Partners with BPI Technologies to Drive Top Line Growth


SAN MATEO, Calif.–(BUSINESS WIRE)–Model N, Inc. (NYSE: MODN), the leading provider of cloud-based revenue management solutions to life sciences and high tech companies, today announced it has partnered with BPI Technologies Corporation, a recognized leader in revenue recognition solutions, to help our customers make faster, smarter, better-informed business decisions, and maximize profit.

“We are very happy to announce the partnership of our gross-to-net revenue application with the Model N revenue execution platform”

Tweet this

The Model N and BPI partnership will provide customers seamless integration that combines comprehensive structural and transactional data across commercial, government, and chargeback channels from Model N with a sophisticated gross-to-net (GTN) revenue recognition offering from BPI. Together, the Model N BPI Gross-to-Net solution will provide customers with fast and complete visibility into pre-deal analysis, the true price of products, true net revenue, accurate accruals, full audit reporting, and reliable forecasts that are critical to pharmaceutical and medical technology manufacturers.

“We are very happy to announce the partnership of our gross-to-net revenue application with the Model N revenue execution platform,” said Richard L. Burcham, chief executive officer at BPI Technologies Corporation. “Based on new data from IQVIA, manufacturers of brand-name drugs in 2017 reduced list price revenues by an astonishing $153 billion—a new high and twice what it was only 5 years ago. Our combined solution will help our customers achieve higher net revenue and reduce the risk associated with gross-to-net forecasting, accrual management and reporting.”

By driving top-line growth through Model N’s revenue execution platform, and by understanding the true prices and revenues together with sophisticated “what if” analysis within a mature gross-to-net joint solution, customers will be able to make better-informed business decisions to achieve both maximum growth and increased profitability.

“We are thrilled to be working with BPI to combine Model N’s trusted transaction data sets with BPI’s advanced analytics tools,” said Jason Blessing, president and chief executive officer at Model N. “Together we will provide complete gross-to-net visibility in near-real-time at each step of the revenue lifecycle. This further builds upon Model N’s position as a critical solution provider for the healthcare ecosystem.”

About Model N

Model N is the leader in revenue management solutions. Driving mission-critical business processes such as contract and rebate management, business intelligence, and regulatory compliance, Model N solutions transform the revenue lifecycle from a series of disjointed operations into a strategic end-to-end process. With deep industry expertise, Model N supports the complex business needs of the world’s leading brands in pharmaceutical, medical device, high tech, manufacturing and semiconductors across more than 120 countries, including Pfizer, AstraZeneca, Sanofi, Gilead, Abbott, Stryker, AMD, Micron, Seagate, STMicroelectronics, NXP, Sesotech, and Southern States. For more information, visit Model N® is the registered trademark of Model N, Inc. Any other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.

About BPI

BPI is a forward-looking company and believes in investing in a vision of today that can become a reality tomorrow. Transformation of Gross-to-Net processes is one such area of interest. From business models to technology, BPI’s gross-to-net solution is helping companies achieve end-to-end transformation of GTN across all channels of their business. Key to transformation is the flexibility and scalability to configure our application to address the ever-changing complexity of the commercial and regulatory environments.


Sherri Walkenhorst,


Allen Fischer CPA

3306 Chadwell Dr

Dallas, TX 75234

972-333-4729 mobile

866-850-2108 efax

Top 10 Enterprise Software Solution Providers-2017

From business models to technology, the pharmaceutical and life sciences industry is currently undergoing a drastic transformation. While economic factors drive business models, the need for realistic insights into
market dynamics is driving the inclination towards information technology and enterprise software. Today, old and legacy systems are being replaced with cutting-edge software capable of collecting, managing, mining and warehousing, analyzing, and even sharing data captured in real-time.

BPI and Genpact form partnership

BPI and Genpact form partnership to help Life Sciences companies transform Gross-to-Net operations. Genpact’s Lean DigitalSM approach harnesses BPI’s GTN Revenue Recognition Suite R2TM in a turnkey cloud-based solution supporting business decisions to grow profits and enhance commercial and regulatory compliance.

BPI Shines at CBI’s GTN 2014 Forum

BPI and BPI’s GTN Revenue Recognition R2 product spotlighted the heavily attended annual CBI GTN event.  Richard Burcham, BPI’s President, based on his GTN thought leadership, moderated the GTN Executive Panel.  BPI’s Steven Birnbach, PMO Director, lead the BPO Panel, and John Lewis, BPI’s Director of Product Development, demonstrated BPI’s end-to-end GTN R2 product at CBI’s four-45 minute GTN Solutions Summit. George Thompson, BPI’s VP of Marketing and Sales stated “I am so proud of BPI sponsorship and leadership in this annual event.  Improvement in and automation of the GTN end-to-end process is the one area where companies can reap significant business benefit and actually pay back all of their past costly investments in contract and revenue management.”